Mo Dimbil
Impact in
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacology top 10%
- Drug-Induced Adverse Reactions
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 4
-
- Pharmaceutical industry and healthcare 3
- Co-authors
- Keith B. Hoffman (7 shared papers)Nicholas P. Tatonetti (4 shared papers)Christina N. Kraus (1 shared paper)Beatrice A. Golomb (1 shared paper)J. Nicholas O’Donnell (1 shared paper)Jonathan Weinstock (1 shared paper)Matthew S. Duprey (1 shared paper)Nada S. Al‐Qadheeb (1 shared paper)
- Journals
- Drug Safety (4 papers)Journal of Managed Care & Specialty Pharmacy (1 paper)PLoS ONE (1 paper)Drugs - Real World Outcomes (1 paper)
- Partner nations
- United States
In The Last Decade
Mo Dimbil
7 papers receiving 442 citations
Peers
Comparison fields: 5 of 95
- Toxicology 144
- Pharmacology 45
- Rheumatology 70
- Internal Medicine 15
- Geriatrics and Gerontology 14
Countries citing papers authored by Mo Dimbil
This map shows the geographic impact of Mo Dimbil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Dimbil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Dimbil more than expected).
Fields of papers citing papers by Mo Dimbil
This network shows the impact of papers produced by Mo Dimbil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Dimbil. The network helps show where Mo Dimbil may publish in the future.
Co-authors
The 10 scholars most cited alongside Mo Dimbil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 131 | |
| 2 | 2017 | 110 | |
| 3 | 2012 | 93 | |
| 4 | 2014 | 85 | |
| 5 | 2016 | 26 | |
| 6 | 2019 | 5 | |
| 7 | 2015 | 5 |
About Mo Dimbil
Mo Dimbil is a scholar working on Toxicology, Pharmacology, Economics and Econometrics, Statistics and Probability and Surgery, having authored 7 papers that have together received 455 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (4 papers), Pharmaceutical industry and healthcare (3 papers), Statistical Methods in Clinical Trials (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Pharmaceutical Economics and Policy (2 papers), Lipoproteins and Cardiovascular Health (1 paper), Anesthesia and Sedative Agents (1 paper) and Biosimilars and Bioanalytical Methods (1 paper). The work is most often cited by research in Toxicology (144 citations), Pharmacology (45 citations), Rheumatology (70 citations), Internal Medicine (15 citations) and Geriatrics and Gerontology (14 citations). Mo Dimbil has collaborated with scholars based in United States. Frequent co-authors include Keith B. Hoffman, Nicholas P. Tatonetti, Christina N. Kraus, Beatrice A. Golomb, J. Nicholas O’Donnell, Jonathan Weinstock, Matthew S. Duprey, Nada S. Al‐Qadheeb, Christopher Madias and John W. Devlin. Their work appears in journals such as Drug Safety, Journal of Managed Care & Specialty Pharmacy, PLoS ONE and Drugs - Real World Outcomes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.